4-Chlorobenzo[b]thiophene CAS 66490-33-3 Kemurnian >98,0% (GC) Brexpiprazole Intermediate Factory

Katrangan singkat:

Jeneng Kimia: 4-Chlorobenzo[b]thiophene

CAS: 66490-33-3

Kemurnian:> 98,0% (GC)

Penampilan: Cairan tanpa warna

Intermediate saka Brexpiprazole (CAS: 913611-97-9)

Kualitas Tinggi, Produksi Komersial

E-Mail: alvin@ruifuchem.com

Kirimi email kanggo kita

Detail Produk

Produk sing gegandhengan

Tag produk

katrangan:

Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]tiofen CAS 5118-13-8
1-(1-Benzothiophen-4-yl) piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-siji CAS 913613-82-8
4-Chlorobenzo[b]tiofen CAS 66490-33-3

Sifat Kimia:

Jeneng Kimia	4-Klorobenzo[b]tiofen
sinonim	4-Chloro-Benzo[b]tiofen;4-Chloro-1-Benzothiophene;4-Chlorobenzothiophene
Nomer CAS	66490-33-3
Nomer CAT	RF-PI1983
Status Simpenan	Ing Simpenan, Skala Produksi Nganti Ton
Formula Molekul	C8H5ClS
Bobot Molekul	168.64
Merk	Kimia Ruifu

Spesifikasi:

Item	Spesifikasi
Penampilan	Cairan Tanpa Warna
Kemurnian / Metode Analisis	> 98,0% (GC)
Total Impurities	<2.00%
Spektrum Infra Merah	Conforms kanggo Struktur
NMR	Conforms kanggo Struktur
Test Standar	Standar Perusahaan
Panggunaan	Intermediate saka Brexpiprazole (CAS: 913611-97-9)

Paket & Panyimpenan:

Paket: Botol Fluorinated, 25kg / Drum, utawa miturut kabutuhan pelanggan

Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan

Kaluwihan:

FAQ:

Aplikasi:

4-Chlorobenzo[b]thiophene (CAS: 66490-33-3) minangka Intermediate Brexpiprazole (CAS: 913611-97-9).Brexpiprazole minangka obat antipsikotik novel sing dadi modulator aktivitas dopamin serotonin ® lan wis nuduhake khasiat minangka perawatan tambahan ing pasien kanthi gangguan depresi utama (MDD).Obat kasebut nuduhake profil farmakologis sing unik, tumindak minangka agonis parsial saka reseptor serotonin 5-HT1A lan dopamin D2 lan minangka antagonis lengkap reseptor 5-HT2A lan noradrenalin α1B / 2C, kanthi afinitas ikatan subnanomolar sing padha.Obat kasebut, sing dikembangake dening Otsuka lan Lundbeck, disetujoni ing 2015 dening FDA kanggo perawatan skizofrenia lan minangka perawatan tambahan kanggo depresi.Brexpiprazole dianggep minangka penerus obat antipsikotik Otsuka aripiprazole (jeneng dagang Abilify) sing paten kadaluwarsa ing Agustus 2014.